DiLab

DiLab is a privately held company located in New York, New York. Founded in 1983, DiLab employs 32 people and generates an annual revenue of $1 million. DiLab is dedicated to developing innovative solutions for automated blood sampling in research settings. The company's flagship product, the AccuSampler, is a fully automated system designed for blood collection from tethered and freely moving research animals. This technology eliminates the need for manual blood sampling, offering increased precision, reduced stress on the animals, and enhanced research efficiency. DiLab's AccuSampler has been recognized for its effectiveness and reliability, leading to collaborations with prominent organizations like Novo Nordisk A/S in Denmark. The company's commitment to advancing automated blood sampling technology has positioned it as a leader in the field. For inquiries or to learn more about DiLab and its products, please visit dilab.com.